Table of Contents
Imagine stepping onto national television, staring down five billionaire investors, and unexpectedly pulling out an Australian didgeridoo. That is exactly how Anders Olmanson kicked off his pitch on the March 18, 2026, episode of Shark Tank (Season 17, Episode 14). He was not there to launch a music career. Instead, he was demonstrating the bizarre but scientifically backed connection between playing wind instruments and curing a problem that plagues millions of American households: snoring.
For decades, the medical industry has treated snoring and sleep apnea with bulky CPAP machines, uncomfortable mouthguards, or painful surgeries. But Olmanson proposed something wildly different. What if you could stop snoring simply by drinking water? His company, REMplenish, turns the everyday act of hydration into a targeted workout for your throat. It sounds entirely too good to be true, which is exactly why the Sharks were initially highly skeptical.
However, the mood in the room shifted dramatically when Olmanson revealed his multi-million dollar sales figures. The ensuing negotiation resulted in a bidding war, a handshake deal, and a wave of national attention. But in the unpredictable world of reality television business, what happens on camera is rarely the end of the story. With the dust settling, the true story behind REMplenish’s explosive growth, a collapsed TV deal, and ongoing clinical trials is far more interesting than a standard reality show pitch.
What is REMplenish?
REMplenish is a consumer health and wellness company that sells a specialized water bottle designed to reduce snoring and improve overall airway health. At first glance, it looks like a standard, high-quality stainless steel or Tritan plastic water bottle. However, the secret lies entirely in the proprietary drinking straw, known as the Myo-Nozzle.
The Myo-Nozzle is not built for easy sipping. It is deliberately designed to provide resistance. When a user drinks water through the REMplenish straw, the nozzle forces them to engage the muscles in their lips, tongue, mouth, and throat. This process is known as myofunctional therapy.
In people who snore or suffer from mild obstructive sleep apnea, the muscles in the back of the throat often become too relaxed during sleep. When these muscles go slack, the tongue falls backward, partially blocking the airway and causing the heavy vibrations we recognize as snoring. By using the REMplenish bottle throughout the day, users actively strengthen those exact airway muscles. It works just like lifting weights at the gym, but for your throat. Over time, the toned muscles stay tighter during sleep, keeping the airway open, encouraging healthy nasal breathing, and significantly quieting the snoring.
The company offers two different resistance levels. Level 1 provides lower resistance and higher water flow for beginners, while Level 2 steps up the difficulty for advanced airway training.
| Product Overview | Details |
|---|---|
| Industry | Health, Wellness & Sleep Tech |
| Founded Year | 2020 (Rebranded from REMastered Sleep in 2025) |
| Core Product | REMplenish Myo-Nozzle Water Bottle |
| Target Audience | Chronic snorers, individuals with mild sleep apnea, mouth breathers |
| Retail Price | $65.00 – $99.95 (depending on size and material) |
Who is the Founder of REMplenish?
The brains behind the Myo-Nozzle is Anders Olmanson, a Minnesota native with a deep background in medical engineering. Long before he stepped onto the Sony Pictures lot to face the Sharks, Olmanson was quietly studying the sleep industry and recognizing a massive, glaring failure in how the medical community treated sleep disorders.
In 2017, while earning his Master of Science in Medical Device Innovation at the University of Minnesota, Olmanson started digging into the statistics surrounding sleep apnea. He uncovered two frustrating facts. First, up to 80% of people suffering from obstructive sleep apnea remain completely undiagnosed. Second, even among those who are diagnosed and prescribed a CPAP machine, the current gold standard for treatment, the compliance rate is terrible. Nearly 40% of patients simply stop using their CPAP machines because they are loud, uncomfortable, and restrictive.
Olmanson wanted a solution that did not require strapping a mask to your face. He began researching alternative therapies and stumbled upon a fascinating, peer-reviewed medical study. The study proved that playing the didgeridoo, a long, wooden aboriginal wind instrument, greatly reduced sleep apnea symptoms because it naturally strengthened the upper airway muscles.
While the science was solid, carrying a massive wooden tube around Minnesota was not a viable consumer product. Olmanson needed to find a way to replicate that specific muscle resistance in a daily habit.
The "aha" moment arrived in 2019, courtesy of a dog. Olmanson was watching a colleague's dog happily working with peanut butter stuck inside a rubber Kong toy. The dog had to use its tongue and throat muscles intensely to extract the treat. Olmanson realized he could apply the exact same mechanical resistance to a human water bottle. He built a team, developed the first prototypes of the Myo-Nozzle, and officially launched the brand under the name REMastered Sleep (which he wisely rebranded to the much catchier "REMplenish" in late 2025).
REMplenish Shark Tank Journey & Pitch
By the time Olmanson walked down the famous Shark Tank hallway in Season 17, Episode 14 (March 18, 2026), he already had a highly functional business. He stepped onto the rug seeking an investment of $400,000 in exchange for 4% equity in REMplenish, giving the company a healthy valuation of $10 million.
The pitch began with a bit of showmanship. Olmanson blew into his didgeridoo to grab the Sharks' attention, then smoothly transitioned into explaining the science of airway collapse during sleep. He handed out samples of the REMplenish bottles to the panel, which included Kevin O’Leary, Robert Herjavec, Lori Greiner, Daniel Lubetzky, and Guest Shark Fawn Weaver.
The Sharks immediately hit a roadblock. When they tried to drink from the bottles, they struggled. The Myo-Nozzle requires genuine effort to pull water through, and Robert Herjavec found the experience highly uncomfortable. He openly laughed at the difficulty, telling Olmanson that consumers want convenience, not a workout, when they are thirsty. Herjavec was the first to drop out, citing the high retail price and the awkward user experience.
Kevin O'Leary echoed Herjavec's concerns, questioning whether the average American would realistically stick to using a water bottle that made drinking a chore. However, Fawn Weaver saw the vision. She understood that this was not a water bottle; it was a daily workout device that happened to hold water.
| Pitch & Offers | Details |
|---|---|
| Initial Ask & Valuation | $400,000 for 4% equity ($10 Million Valuation) |
| Sharks in the Room | Kevin O'Leary, Robert Herjavec, Lori Greiner, Daniel Lubetzky, Fawn Weaver |
| Offers Made | Kevin O'Leary & Daniel Lubetzky: $400,000 for 10% equity |
| Final Deal Accepted | $400,000 for 10% equity (O'Leary & Lubetzky) |
Then came the numbers. When Olmanson revealed that he had reached $3.9 million in lifetime sales primarily through targeted digital advertising, the tone of the room changed from amused to strictly business. The Sharks love a weird product, but they respect cash flow even more.
Daniel Lubetzky, the founder of KIND Snacks, spoke up about his own lifelong battles with insomnia and sleep issues. He understood the desperate market of exhausted people looking for a cure.
Lubetzky and O'Leary decided to team up. They were impressed by the revenue but hated the $10 million valuation. After some aggressive back-and-forth haggling over the equity, Olmanson compromised and accepted their offer of $400,000 for 10%.
What Happened to REMplenish After Shark Tank?
A handshake on national television is never a legally binding contract. Following the March 2026 airing, Forbes investigated the aftermath of the pitch and discovered that the deal with Kevin O'Leary and Daniel Lubetzky never actually closed.
During the standard post-show due diligence phase, where the investors' legal and financial teams comb through the company's books to verify every claim, both parties agreed to walk away. REMplenish officially stated that they "appreciated the opportunity to connect" but ultimately decided to remain independent. This is incredibly common in the Shark Tank world; roughly half of all on-air deals fall through once the cameras stop rolling due to disagreements over control, distribution, or final legal terms.
Despite losing the $400,000 investment, REMplenish gained something far more valuable: prime-time television exposure. The "Shark Tank Effect" hit the company hard. Immediately following the broadcast, the REMplenish website was flooded with orders from desperate snorers and exhausted partners. This massive spike in consumer interest allowed the company to self-fund the very expansion plans they had originally wanted the Sharks' money for.
Is REMplenish Still in Business?
Yes, REMplenish is very much alive, thriving, and expanding rapidly as of late 2026. Bypassing the Shark money did not slow them down. In fact, retaining 100% of their equity gave Olmanson and his team full control over their strategic direction.
The company is currently headquartered in Burnsville, Minnesota, and operates a robust direct-to-consumer digital storefront. Based on the post-show momentum, REMplenish is actively executing two major growth strategies. First, they are expanding their international footprint, specifically targeting European markets where health-conscious consumers are highly receptive to non-invasive therapies. Second, they are shifting from a purely online model to pursuing retail placements in major US pharmacies and health stores.
They have also expanded their product line, introducing a smaller "REMplenish Jr." nozzle aimed specifically at children ages three to nine to help correct mouth-breathing and airway issues early in life.
What is the Valuation & Net Worth of REMplenish?
Because REMplenish is a privately held limited liability company, exact daily profit margins are kept under wraps. However, we can accurately piece together their valuation based on the hard numbers revealed during their TV appearance and subsequent business reports.
Going into the Tank, Olmanson reported $3.9 million in lifetime sales. According to the Minneapolis/St. Paul Business Journal, the company closed out the 2025 fiscal year with roughly $7 million in total revenue. That represents massive, rapid scaling for a niche health product.
When O'Leary and Lubetzky offered $400,000 for 10%, they were valuing the company at $4 million. However, that TV valuation is widely considered to be a "Shark discount."
Given their confirmed $7 million annual revenue in 2025, and applying a conservative 2.5x to 3x multiple standard for high-growth direct-to-consumer health hardware, the estimated 2026 valuation of REMplenish is safely between $15 million and $20 million.
Because the Shark Tank deal fell through, Anders Olmanson and his early investing team still hold the equity. Therefore, the estimated net worth of the REMplenish business structure sits around that $15 million to $20 million mark, representing a massive financial win for the Burnsville startup.
Does REMplenish Actually Work? Clinical Trials & Reviews
When a company claims that drinking water can cure snoring, consumer skepticism is naturally high. However, REMplenish has leaned heavily into the medical and scientific community to back up its marketing.
The company is currently participating in an official clinical trial conducted by the Mayo Clinic and funded by the National Institutes of Health (NIH). While the final peer-reviewed results of the Mayo Clinic trial are still pending publication, preliminary data shows a measurable reduction in both the Apnea Hypopnea Index (AHI) and the time patients spend at low oxygen saturation levels during sleep.
Furthermore, in a 2020 usability study conducted by the brand, 93% of participants reported reduced snoring intensity and frequency after just one month of consistent use.
Customer reviews across the internet echo the Sharks' initial reactions: the product has a steep learning curve. New users frequently complain that their jaw and throat muscles feel sore during the first week of use. However, for myofunctional therapy, that soreness is actually the point, it proves the muscles are being worked. Users who stick with the daily routine for four to six weeks overwhelmingly report deeper sleep, easier nasal breathing, and highly relieved spouses.
Where to Buy REMplenish?
As of today, the best and most reliable place to purchase the Myo-Nozzle is directly through the official REMplenish website. Buying direct ensures you receive the latest version of the nozzle and allows you to take advantage of the company's "Breathe Better Promise," which offers a 90-day return window if your sleep does not improve.
The kits are available in standard Tritan plastic or premium insulated stainless steel, ranging in size from a compact 15-ounce bottle to a heavy-duty 32-ounce jug. Prices generally start at $65.00 for the basic plastic kits and max out around $99.95 for the premium steel bundles that include both Level 1 and Level 2 resistance nozzles.
